急性/亚急性肝衰竭患者急性肾损伤发生率和预后分析*

doi:10.3969/j.issn.1672-5069.2024.02.016

实用肝脏病杂志 ›› 2024, Vol. 27 ›› Issue (2): 222-225.doi: 10.3969/j.issn.1672-5069.2024.02.016

急性/亚急性肝衰竭患者急性肾损伤发生率和预后分析^*

刘松涛, 孟庆华, 刘梅, 韩亚男, 王金环, 闾军

100069 北京市首都医科大学附属北京佑安医院肿瘤内科(刘松涛,孟庆华,刘梅,王金环,闾军);临汾市第三人民医院肝病二科(韩亚男)

收稿日期:2023-02-23 出版日期:2024-02-10 发布日期:2024-03-08
通讯作者: 闾军,E-mail: lujun98@ccmu.edu.cn
作者简介:刘松涛,男,42岁,医学硕士,副主任医师。E-mail:botao8080@163.com
基金资助:
^*北京市医院管理中心“登峰”人才培养计划项目(编号:DFL20221502);北京佑安医院中青年人才联合攻关项目(编号:BJYAYY-GG2019-01)

Prevalence of acute kidney injury and its impact on prognosis in patients with acute/subacute liver failure

Liu Songtao, Meng Qinghua, Liu Mei, et al.

Department of Medical Oncology, You’an Hospital, Capital Medical University, Beijing 100069, China

Received:2023-02-23 Online:2024-02-10 Published:2024-03-08

摘要/Abstract

摘要： 目的分析急性/亚急性肝衰竭(ALF/SALF)患者急性肾损伤(AKI)发生率及其对预后的影响。方法 2016年1月～2021年7月我院收治的ALF/SALF成人患者, 参照2015年国际腹水俱乐部制定的标准诊断AKI, 应用多因素COX生存回归分析影响生存率的因素。结果在纳入的378例患者中, ALF 77例, SALF 301例;91例(24.1%)发生了AKI, 其中ALF患者为42.9%, 显著高于SALF患者的19.3%(P<0.05);在91例AKI患者中, 肾前性氮质血症(PRA)4例(4.4%), 肝肾综合征(HRS)54例(59.3%), 急性肾小管坏死(ATN)22例(24.2%), 其他类型11例(12.1%);未并发AKI的ALF患者28 d和90 d病死率分别为45.5%和47.7%, 显著低于并发AKI的78.8%和90.9%(P<0.05), 未并发AKI的SALF患者28 d和90 d病死率分别为23.0%和26.7%, 显著低于并发AKI患者的69.0%和74.1%(P<0.05);经COX生存回归分析显示, 诊断为ALF、发生AKI和INR高水平与患者28 d和90 d病死率独立相关。结论 ALF患者发生AKI的比例显著高于SALF患者, 也是导致死亡的重要原因。

关键词: 肝衰竭, 急性肾损伤, 预后

Abstract: Objective This study was conducted to analyze the prevalence of acute kidney injury (AKI) and its impact on prognosis in patients with acute/subacute liver failure (ALF/SALF). Methods The patients with ALF/SALF were encountered in our hospital between January 2016 and July 2021, and the AKI was diagnosed based on the criteria proposed by International Club of Ascites in 2015. The multivariate COX survival regression analysis was applied to predict the prognostic factors. Results Out of 378 patients with liver failure, the ALF was diagnosed in 77 cases and SALF in 301 cases; the incidence of AKI in patients with ALF was 42.9%, significantly higher than 19.3% in patients with SALF (P<0.05); among the 91 patients with AKI, the prerenal azotemia (PRA) was found in 4 cases (4.4%), the hepatorenal syndrome (HRS) in 54 (59.3%), the acute tubular necrosis (ATN) in 22 (24.2%) and other types of renal injuries in 11 cases (12.1%); the 28-day and 90-day fatality rates in patients with ALF without AKI were 45.5% and 47.7%, much lower than 78.8% and 90.9%(P<0.05) in patients with AKI, and the 28-day and 90-day fatality rates in patients with SALF without AKI were 23.0% and 26.7%, much lower than 69.0% and 74.1%(P<0.05) in those with AKI; the multivariate COX survival regression analysis showed that the occurrence of ALF, complicated AKI and high level of INR were the independent risk factors for 28-day and 90-day survival in patients with ALF/SALF. Conclusion The complicated AKI in patients with liver failure is common, especially in those with ALF, which hints poor prognosis, and needs urgent management properly.

Key words: Liver failure, Acute kidney injury, Prognosis

刘松涛, 孟庆华, 刘梅, 韩亚男, 王金环, 闾军. 急性/亚急性肝衰竭患者急性肾损伤发生率和预后分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 222-225.

Liu Songtao, Meng Qinghua, Liu Mei, et al.. Prevalence of acute kidney injury and its impact on prognosis in patients with acute/subacute liver failure[J]. Journal of Practical Hepatology, 2024, 27(2): 222-225.

参考文献

[1] 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版). 实用肝脏病杂志, 2019,22(2):164-171.
[2] Kim TY, Song DS, Kim HY, et al. Characteristics and discrepancies in acute-on-chronic liver failure: Need for a unified definition. PLoS One, 2016,11(1):e0146745.
[3] Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol, 2015,13(2):352-359.
[4] Wlodzimirow KA, Eslami S, Abu-Hanna A, et al. Systematic review: Acute liver failure - one disease, more than 40 definitions. Aliment Pharmacol Ther, 2012,35(11):1245-1256.
[5] Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology, 2005,41(5):1179-1197.
[6] Acharya SK, Batra Y, Hazari S, et al. Etiopathogenesis of acute hepatic failure: Eastern versus western countries. J Gastroenterol Hepatol, 2002,17(Suppl 3):S268-273.
[7] Khuroo MS, Kamili S. Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat, 2003,10(3):224-231.
[8] Wu J, Shi C, Sheng X, et al. Prognostic nomogram for patients with hepatitis e virus-related acute liver failure: A multicenter study in china. J Clin Transl Hepatol, 2021,9(6):828-837.
[9] Zhao P, Wang C, Liu W, et al. Causes and outcomes of acute liver failure in china. PLoS One, 2013,8(11):e80991.
[10] Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the international club of ascites. Gut, 2015,64(4):531-537.
[11] Huelin P, Sola E, Elia C, et al. Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: A prospective study. Hepatology, 2019,70(1):319-333.
[12] Angeli P, Garcia-Tsao G, Nadim MK, et al. News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the international club of ascites (ICA) consensus document. J Hepatol, 2019,71(4):811-822.
[13] 臧红, 刘婉姝, 刘鸿凌, 等. 急性肝衰竭并发急性肾损伤的危险因素及对近期预后的影响. 中国肝脏病杂志(电子版), 2016,8(4):66-70.
[14] 陈婧, 刘晓燕, 童晶晶, 等. 急性/亚急性肝衰竭合并急性肾损伤的临床特征分析. 临床肝胆病杂志, 2018,34(2):364-367.
[15] Shen T, Liu Y, Shang J, et al. Incidence and etiology of drug-induced liver injury in mainland china. Gastroenterology, 2019,156(8):2230-2241,e2211.
[16] Flamm SL, Yang YX, Singh S, et al. American gastroenterological association institute guidelines for the diagnosis and management of acute liver failure. Gastroenterology, 2017,152(3):644-647.
[17] Urrunaga NH, Magder LS, Weir MR, et al. Prevalence, severity, and impact of renal dysfunction in acute liver failure on the US liver transplant waiting list. Dig Dis Sci, 2016,61(1):309-316.
[18] Choudhary NS, Saigal S, Saraf N, et al. Liver transplantation for acute liver failure in presence of acute kidney injury. J Clin Exp Hepatol, 2020,10(2):170-176.

急性/亚急性肝衰竭患者急性肾损伤发生率和预后分析^*

Prevalence of acute kidney injury and its impact on prognosis in patients with acute/subacute liver failure

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	梁丹丹, 江建宁, 黄锦妮, 龙诗雨, 董国珍, 苏曼, 李继娇, 滕春玲, 张萍, 苏明华. 219例药物性肝损伤患者临床特征和预后分析^*[J]. 实用肝脏病杂志, 2024, 27(2): 210-213.
[2]	杨晶, 陈美玲, 张丽秀, 颜鲁伟, 白正强, 贺锐. 慢加急性乙型肝炎肝衰竭患者细菌感染病原菌分布及血清PCT、IFN-γ和IL-6水平变化分析^*[J]. 实用肝脏病杂志, 2024, 27(1): 64-67.
[3]	何圣科, 蒲江汉, 冯海玲, 吴大平, 陈绵军, 陈辉. 肝细胞癌组织HOXC9和KIF4A表达及其临床意义探讨^*[J]. 实用肝脏病杂志, 2024, 27(1): 84-87.
[4]	张玥, 宁玲, 李文渊, 郑晓玮, 刘洪涛, 张振华, 李磊. 血清HBsAg阳性者接受肾移植术120周预后随访报告^*[J]. 实用肝脏病杂志, 2023, 26(6): 797-800.
[5]	王新月, 周莉, 董金玲, 陈煜. 双重血浆分子吸附系统治疗肝衰竭患者应用甲磺酸萘莫司他与肝素抗凝有效性与安全性比较研究^*[J]. 实用肝脏病杂志, 2023, 26(6): 843-846.
[6]	李菲, 陈辛未, 李琦. HBV相关慢加急性肝衰竭患者血清GP73、suPAR和AT-Ⅲ水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 847-850.
[7]	赖华梅, 王俊, 杨玉健. 肝衰竭患者外周血单个核细胞hTERT mRNA及血清Ang-2和ICAM-1水平临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 851-854.
[8]	杨婉, 丁莉, 罗珂, 刘美. 肝细胞癌患者癌组织CK7和Glypican-3表达及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 883-886.
[9]	孙岩, 张鑫, 李国宾, 闫尚伦, 徐良. 接受根治性肝切除术治疗的肝内胆管细胞癌患者肿瘤组织成纤维细胞生长因子受体2表达及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(6): 907-910.
[10]	常凯, 黄亚秋, 于立丽, 熊建新, 杨明. 肝硬化并发肝肾综合征患者血清细胞因子和外周血淋巴细胞亚群变化及短期预后分析^*[J]. 实用肝脏病杂志, 2023, 26(5): 678-681.
[11]	冯冬霞, 奚晶, 杨振斌, 刘亚芹, 胡茜莹. 乙型肝炎肝硬化并发自发性细菌性腹膜炎患者外周血单个核细胞NLRP3和Caspase-1水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(5): 682-685.
[12]	张觅, 胡桂华, 邹鹏程. 乙型肝炎肝硬化并发急性肾损伤患者血清和尿液NGAL、IGFBP7和TIMP-2水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2023, 26(5): 690-693.
[13]	蓝春雨, 范丽琴, 颜状, 王小龙, 朱加猛. 影响肝叶切除术治疗的原发性肝癌患者长期生存的因素分析^*[J]. 实用肝脏病杂志, 2023, 26(5): 698-701.
[14]	仁增卓嘎, 王志鑫, 尹凤娇, 王海久. 抗菌肽抑制Caspase-3表达对内毒素诱导的急性肝衰竭小鼠肝细胞凋亡的影响^*[J]. 实用肝脏病杂志, 2023, 26(4): 472-475.
[15]	张亦瑾, 高学松, 高丽丽, 郝一炜, 段雪飞. 儿童与成人肝豆状核变性患者临床特征和生存分析^*[J]. 实用肝脏病杂志, 2023, 26(4): 520-523.